Life‐Threatening Cytopenias in a Jehovah's Witness Following CD19‐Directed Chimeric Antigen Receptor T Cell Therapy

ABSTRACT Here we report on a Jehovah's Witness (JW) patient who experienced profound and prolonged life‐threatening cytopenias following CD19‐targeted CAR T cell therapy, successfully managed with bloodless medicine strategies. This case highlights the potential risks of CAR T therapy, even in...

Full description

Bibliographic Details

Published in:	eJHaem
Main Authors:	Corinne J. Shamehdi, Christian A. Gordillo, Ahmed Sawas, Rodney Macedo, Markus Y. Mapara, Ran Reshef
Format:	Article
Language:	English
Published:	Wiley 2025-08-01
Subjects:	cell therapy cytopenia Jehovah's witness lymphomas
Online Access:	https://doi.org/10.1002/jha2.70119